Tech Company Financing Transactions
Grow Therapy Funding Round
On 9/29/2022, Grow Therapy received $75 million in Series B funding from TCV, Transformation Capital and SignalFire.
Transaction Overview
Company Name
Announced On
9/29/2022
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors
TCV (Lead Investor) (Gautam Gupta)
Transformation Capital (Lead Investor)
Proceeds Purpose
This new round of funding will be used to expand our insurance coverage and improve the provider and patient experiences.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
141 West 24 St.
New York, NY 10011
USA
New York, NY 10011
USA
Phone
Undisclosed
Website
Email Address
Overview
We believe therapy is an essential part of becoming the best versions of ourselves. No matter who you are or where you are starting, it's more than support through challenge -- it's the foundation to grow, heal and lead lives that are more resilient, empathic, hopeful and powerful.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jake Cooper
Browse more venture capital transactions:
Prev: 9/29/2022: Phenix venture capital transaction
Next: 9/29/2022: Invers venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs